Position: The Council Chairman of China Anti-Cancer Association
Title: the Academician of Chinese Academy of Engineering
Specialty: Prof. Fan Daiming has long been engaged in the basic and clinical research of digestive diseases. Specifically, he has made great contributions to the molecular mechanism, control and prevention of the occurrence and development of gastric cancer.
Introduction:
The Council Chairman of China Anti-Cancer Association, the Former Vice President of Chinese Academy of Engineering, the Academician of Chinese Academy of Engineering, the Foreign associate of the USA National Academy of Medicine, the Foreign associate of French National Academy of Medicine, the Member of Committee of Education, Science, Culture and Health of 13rd National People's Congress, the President of Asian Pacific Association of Gastroenterology.
Prof. Fan Daiming has long been engaged in the basic and clinical research of digestive diseases. Specifically, he has made great contributions to the molecular mechanism, control and prevention of the occurrence and development of gastric cancer.
Medical Experience:
He once undertook the national “863”,“973”, national research, national major new drug development, National Natural Science Foundation key projects and other topics. He has won the National Science and Technology Progress Award and the National Technological Invention Award. Prof. Fan Daiming developed a national Class I diagnostic reagent with independent intellectual property rights - Gastric cancer immune PCR serum diagnostic kit. He edited 11 books, published 257 papers in foreign journals as the leading author or corresponding author, and was invited to do 10 invited reviews in 9 international professional journals such as J Gastroenterol Hepatol.
Research Direction:
Diagnosis and treatment of gastroenteric diseases, including digestive system tumors.
*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.